Navigation Links
US Oncology Pharmaceutical Distribution Service Wins National Safety Council Award
Date:9/3/2008

HOUSTON, Sept. 3 /PRNewswire/ -- US Oncology Specialty, LP, the state-of-the-art pharmaceutical distribution center of US Oncology, has received the Occupational Excellence Achievement Award from the National Safety Council for its outstanding safety achievements.

The award is presented to companies who produce the "best of the best" in safety and safety performance. To be eligible, organizations must report days away from work resulting from workplace injuries or illness at a rate equal to or less than 50 percent of the Bureau of Labor Statistics (BLS) rate for their classification code. The BLS rate for US Oncology Specialty's classification code is 0.9 percent; in order to qualify the organization had to report an incident rate of .45 percent or lower. In 2007, US Oncology Specialty, employing 32 employees, achieved a lost workday incidence rate of zero percent.

US Oncology Specialty was launched in 2005 to manage the ordering and delivery of approximately $1.8 billion of pharmaceuticals each year for its affiliated network of community-based oncologists. The organization has focused on ensuring the protection of employees and patients by investing in systems and security measures that produce results. The industry-leading distribution service was the first oncology distributor to achieve the National Association of Boards of Pharmacy's (NABP) Verified-Accredited Wholesale Distributors (VAWD) accreditation to implement electronic pedigree technology, ensuring that pharmaceuticals are securely tracked, from the manufacturer to the patient, for optimum security and safety.

Additionally, the organization has twice received the Occupational Excellence Award from the Texas chapter of the National Safety Council.

About US Oncology, Inc.

US Oncology, headquartered in Houston, works closely with physicians, manufacturers and payers to identify and deliver innovative services that enhance patient access to advanced cancer care. US Oncology supports one of the nation's foremost cancer treatment and research networks accelerating the availability and use of evidence-based medicine and shared best practices.

US Oncology's expertise in supporting every aspect of the cancer care delivery system -- from drug development to treatment and outcomes measurement, enables the company to help increase the efficiency and safety of cancer care. According to the company's last quarterly earnings report, US Oncology is affiliated with 1,247 physicians operating in 472 locations, including 91 radiation oncology facilities in 39 states. For more information, visit the company's Web site, http://www.usoncology.com.


'/>"/>
SOURCE US Oncology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. MD Anderson Becomes a GeneGo Center of Excellence Using MetaCore for Oncology Research
2. US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services
3. Poniard Pharmaceuticals to Present at the 4th Annual Moores UCSD Cancer Center Translational Oncology Symposium
4. US Oncology to Report 2008 Second Quarter Earnings Results
5. Texas Oncology-Baylor Sammons Cancer Center Recognized for Highest Commitment to Clinical Research at ASCO
6. US Oncology Manufacturing-Inspired Practice Management Model Producing Quality and Efficiency Improvements
7. Access Licenses ProLindac(TM) to Jiangsu Aosaikang Pharmaceutical Co., LTD., a Leading Oncology Pharmaceutical Company for Manufacturing, Development and Commercialization in the Greater China Region
8. ACORN Expands Oncology Information Portfolio With Comprehensive Data Warehouse
9. Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting
10. Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs
11. EUSA Pharma Divests Monoclonal Antibody Research Business and Early-Stage Oncology Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, ... microbial test has received AOAC Research Institute approval 061601. , “This is another ... year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel ...
Breaking Biology Technology:
(Date:6/15/2016)... York , June 15, 2016 ... new market report titled "Gesture Recognition Market by Application ... Forecast, 2016 - 2024". According to the report, the  ... 11.60 billion in 2015 and is estimated to ... USD 48.56 billion by 2024.  Increasing ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/2/2016)... 2, 2016   The Weather Company , an IBM ... an industry-first capability in which consumers will be able to ... ask questions via voice or text and receive relevant information ... Marketers have long sought an advertising solution that ... be personal, relevant and valuable; and can scale across millions ...
Breaking Biology News(10 mins):